Literature DB >> 16356932

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes.

Dimitri Lavillette1, Birke Bartosch, Delphine Nourrisson, Géraldine Verney, François-Loïc Cosset, François Penin, Eve-Isabelle Pécheur.   

Abstract

It has been suggested that the hepatitis C virus (HCV) infects host cells through a pH-dependent internalization mechanism, but the steps leading from virus attachment to the fusion of viral and cellular membranes remain uncharacterized. Here we studied the mechanism underlying the HCV fusion process in vitro using liposomes and our recently described HCV pseudoparticles (pp) bearing functional E1E2 envelope glycoproteins. The fusion of HCVpp with liposomes was monitored with fluorescent probes incorporated into either the HCVpp or the liposomes. To validate these assays, pseudoparticles bearing either the hemagglutinin of the influenza virus or the amphotropic glycoprotein of murine leukemia virus were used as models for pH-dependent and pH-independent entry, respectively. The use of assays based either on fusion-induced dequenching of fluorescent probes or on reporter systems, which produce fluorescence when the virus and liposome contents are mixed, allowed us to demonstrate that HCVpp mediated a complete fusion process, leading to the merging of both membrane leaflets and to the mixing of the internal contents of pseudoparticle and liposome. This HCVpp-mediated fusion was dependent on low pH, with a threshold of 6.3 and an optimum at about 5.5. Fusion was temperature-dependent and did not require any protein or receptor at the surface of the target liposomes. Most interestingly, fusion was facilitated by the presence of cholesterol in the target membrane. These findings clearly indicate that HCV infection is mediated by a pH-dependent membrane fusion process. This paves the way for future studies of the mechanisms underlying HCV membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356932     DOI: 10.1074/jbc.M509747200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica.

Authors:  Lukmanee Tradtrantip; Hua Zhang; Marc O Anderson; Samira Saadoun; Puay-Wah Phuan; Marios C Papadopoulos; Jeffrey L Bennett; A S Verkman
Journal:  FASEB J       Date:  2012-02-08       Impact factor: 5.191

2.  A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.

Authors:  Heidi E Drummer; Irene Boo; Anne L Maerz; Pantelis Poumbourios
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion.

Authors:  Nishi R Sharma; Guaniri Mateu; Marlene Dreux; Arash Grakoui; François-Loïc Cosset; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

Review 4.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

5.  Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Authors:  Emmanuelle Blanchard; Sandrine Belouzard; Lucie Goueslain; Takaji Wakita; Jean Dubuisson; Czeslaw Wychowski; Yves Rouillé
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.

Authors:  Ana M Chamoun-Emanuelli; Eve-Isabelle Pecheur; Rudo L Simeon; Da Huang; Paul S Cremer; Zhilei Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

7.  Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.

Authors:  Marlène Dreux; Viet Loan Dao Thi; Judith Fresquet; Maryse Guérin; Zélie Julia; Géraldine Verney; David Durantel; Fabien Zoulim; Dimitri Lavillette; François-Loïc Cosset; Birke Bartosch
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

8.  A computational approach identifies two regions of Hepatitis C Virus E1 protein as interacting domains involved in viral fusion process.

Authors:  Roberto Bruni; Angela Costantino; Elena Tritarelli; Cinzia Marcantonio; Massimo Ciccozzi; Maria Rapicetta; Gamal El Sawaf; Alessandro Giuliani; Anna Rita Ciccaglione
Journal:  BMC Struct Biol       Date:  2009-07-29

Review 9.  Hepatitis C Virus entry: the early steps in the viral replication cycle.

Authors:  Ali Sabahi
Journal:  Virol J       Date:  2009-07-30       Impact factor: 4.099

10.  Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry.

Authors:  Hsiao-Fen Li; Chia-Hsuan Huang; Li-Shuang Ai; Chin-Kai Chuang; Steve S L Chen
Journal:  J Biomed Sci       Date:  2009-09-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.